Loading…
Digital Pharma Innovation Week has ended
avatar for Judy Stewart

Judy Stewart

GSK
Senior Vice President, US Vaccines
Judy Stewart is the Senior Vice President of the Vaccines Business Unit of GSK’s US Pharmaceuticals business.  Judy sits on the US Pharma Commercial Leadership Team (CLT), the Global Vaccines Investment Board (VIB), which is focused on vaccines R&D investments, and is co-chair of BIO’s Vaccines Policy Advisory Committee (VPAC).  Judy has more than 20 years of healthcare industry experience.  She joined GSK 17 years ago in pediatric vaccines and over the course of her career at GSK, she has taken on roles of increasing leadership responsibility across the enterprise, both in the US and globally, in a range of functions including marketing and learning and development.  She also served as the Vice President and General Manager of Denmark and Iceland. Prior to her 2019 appointment to manage the US Vaccines business, Judy led the US Vaccines marketing team for two years. During that time she oversaw the commercial strategy for the full US vaccines portfolio, including the meningitis franchise and the launch of SHINGRIX. She holds a BA from the University of Maryland and an MBA from Drexel University.